Breakthrough Announcement Propels Applied Therapeutics (APLT) Stock To Impressive Gains
Applied Therapeutics, Inc. (NASDAQ: APLT) witnessed a notable surge of 39.93% in its stock price on Thursday, culminating in a closing figure of $3.75. This significant uptick in APLT stock followed the release of encouraging interim results from a clinical trial. Applied Therapeutics (APLT) disclosed positive interim findings from the ongoing Phase 3 INSPIRE trial, […]